Rare diseases
Investigational molecules
Locations
Back to Czechia7 clinical trials in Prostejov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
CzechiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CzechiaStudy on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on atherosclerotic cardiovascular disease prevention and treatment. Research aims to evaluate new therapeutic approaches for reducing major cardiovascular events.
Novel investigations into emergency interventions for acute myocardial infarction, including self-administered treatments.
Innovative research examining treatments for atrial fibrillation, focusing on preventing cardioembolic events and improving patient outcomes.
Advanced therapeutic approaches comparing new anticoagulation strategies with established treatments.
Comprehensive studies investigating treatments for ulcerative colitis and rheumatoid arthritis, evaluating long-term safety and efficacy of innovative therapies.
Research focuses on comparing various treatment options and their effectiveness in managing inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
